Shoji Kubo
- Hepatology top 0.1%
- Hepatocellular Carcinoma Treatment and Prognosis 188
- Hepatitis C virus research 48
- Liver Disease and Transplantation 38
- Surgery top 0.5%
- Cholangiocarcinoma and Gallbladder Cancer Studies 160
- Pediatric Hepatobiliary Diseases and Treatments 35
- Oncology top 1%
- Pancreatic and Hepatic Oncology Research 56
- Epidemiology top 0.5%
- Liver Disease Diagnosis and Treatment 117
-
- Gallbladder and Bile Duct Disorders 56
- Co-authors
- Kazuhiro HirohashiHiroaki KinoshitaHiromu TanakaShigekazu TakemuraTakahiro UenishiTakatsugu YamamotoShogo TanakaTaichi Shuto
- Cited by
- HepatologySurgeryOncology
- Journals
- Journal of Clinical Oncology (3 papers)SHILAP Revista de lepidopterología (4 papers)Annals of Internal Medicine (1 paper)
- Partner nations
- JapanUnited StatesFrance
In The Last Decade
Shoji Kubo
436 papers receiving 9.1k citations
Peers
Comparison fields: 5 of 129
- Hepatology 4.9k
- Surgery 4.3k
- Oncology 2.5k
- Epidemiology 3.2k
- Pulmonary and Respiratory Medicine 2.2k
Countries citing papers authored by Shoji Kubo
This map shows the geographic impact of Shoji Kubo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shoji Kubo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shoji Kubo more than expected).
Fields of papers citing papers by Shoji Kubo
This network shows the impact of papers produced by Shoji Kubo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shoji Kubo. The network helps show where Shoji Kubo may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Shoji Kubo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2024 | 1 | |
| 3 | 2024 | 1 | |
| 4 | 2023 | 17 | |
| 5 | 2023 | 16 | |
| 6 | 2023 | 7 | |
| 7 | 2023 | 6 | |
| 8 | 2022 | 9 | |
| 9 | 2021 | 4 | |
| 10 | 2021 | 6 | |
| 11 | 2020 | 14 | |
| 12 | 2019 | 27 | |
| 13 | 2019 | 59 | |
| 14 | 2018 | 4 | |
| 15 | 2017 | 48 | |
| 16 | 2017 | 10 | |
| 17 | 2017 | 177 | |
| 18 | 2016 | 28 | |
| 19 | Different carcinogenic process in cholangiocarcinoma cases epidemically developing among workers of a printing company in Japan. | 2014 | 29 |
| 20 | 2009 | 1 |
About Shoji Kubo
Shoji Kubo is a scholar working on Hepatology, Surgery and Oncology, having authored 460 papers that have together received 9.3k indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (188 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (160 papers), Liver Disease Diagnosis and Treatment (117 papers), Pancreatic and Hepatic Oncology Research (56 papers), Gallbladder and Bile Duct Disorders (56 papers), Hepatitis C virus research (48 papers), Liver Disease and Transplantation (38 papers) and Pediatric Hepatobiliary Diseases and Treatments (35 papers). The work is most often cited by research in Hepatology (4.9k citations), Surgery (4.3k citations) and Oncology (2.5k citations). Shoji Kubo has collaborated with scholars based in Japan, United States and France. Frequent co-authors include Kazuhiro Hirohashi, Hiroaki Kinoshita, Hiromu Tanaka, Shigekazu Takemura, Takahiro Uenishi, Takatsugu Yamamoto, Shogo Tanaka, Taichi Shuto, Akihiro Tamori and Shuhei Nishiguchi. Their work appears in journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Annals of Internal Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.